[Federal Register Volume 61, Number 75 (Wednesday, April 17, 1996)]
[Notices]
[Pages 16803-16804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9388]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Jamal Z. Farooqui, Ph.D., University of Cincinnati College of 
Medicine (UCCM): Based on an investigation conducted by the institution 
as well as information obtained by ORI during its oversight review, ORI 
found that Jamal Z. Farooqui, Ph.D., Research Associate Professor, 
Department of Dermatology at UCCM, committed scientific misconduct by 
plagiarizing material in a Public Health Service (PHS) grant 
application from an application another research as submitted to the 
National Science Foundation (NSF). Dr. Farooqui received the NSF 
application from another faculty member at UCCM while that application 
was undergoing confidential peer review. Dr. Farooqui included the 
plagiarized material in the ``Prospective Significance'' and 
``Methodology'' sections of his application entitled 
``Proopimelanocortin expression in human epidermis,'' submitted to the 
National Institute of Arthritis and Musculosketetal and Skin Diseases.
    Dr. Farooqui has entered into a Voluntary Exclusion Agreement with 
ORI in which he has voluntarily agreed, for the three (3) year period 
beginning April 3, 1996:
    (1) that he is required to certify in every PHS research 
application or report that all contributors to the application or 
report are properly cited or otherwise acknowledged, that an 
institutional official must endorse the certification, and that the 
institution must send a copy of the certification to ORI; and
    (2) to exclude himself from serving in any advisory capacity to 
PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.
    No scientific publications were required to be corrected as part of 
this Agreement.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research

[[Page 16804]]

Integrity, 5515 Security Lane, Suite 700, Rockville, MD 20852.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 96-9388 Filed 4-16-96; 8:45 am]
BILLING CODE 4160-17-M